日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Correction: Rapid resolution of migraine symptoms after initiating the preventive treatment eptinezumab during a migraine attack: results from the randomized RELIEF trial

更正：在偏头痛发作期间开始预防性治疗 eptinezumab 后，偏头痛症状迅速缓解：来自随机 RELIEF 试验的结果

期刊:BMC Neurology
影响因子:2.2
doi:10.1186/s12883-023-03368-3
Ailani, Jessica; McAllister, Peter; Winner, Paul K; Chakhava, George; Josiassen, Mette Krog; Lindsten, Annika; Sperling, Bjørn; Ettrup, Anders; Cady, Roger
偏头痛
神经科学
发表日期：2023
文献求助 收藏

Eptinezumab treatment initiated during a migraine attack is associated with meaningful improvement in patient-reported outcome measures: secondary results from the randomized controlled RELIEF study

在偏头痛发作期间开始使用依普汀单抗治疗与患者报告结局指标的显著改善相关：来自随机对照 RELIEF 研究的次要结果

期刊:Journal of Headache and Pain
影响因子:7.9
doi:10.1186/s10194-021-01376-7
McAllister, Peter; Winner, Paul K; Ailani, Jessica; Buse, Dawn C; Lipton, Richard B; Chakhava, George; Josiassen, Mette Krog; Lindsten, Annika; Mehta, Lahar; Ettrup, Anders; Cady, Roger
偏头痛
神经科学
发表日期：2022
文献求助 收藏

Rapid resolution of migraine symptoms after initiating the preventive treatment eptinezumab during a migraine attack: results from the randomized RELIEF trial

在偏头痛发作期间开始预防性治疗 eptinezumab 后，偏头痛症状迅速缓解：来自随机 RELIEF 试验的结果

期刊:BMC Neurology
影响因子:2.2
doi:10.1186/s12883-022-02714-1
Ailani, Jessica; McAllister, Peter; Winner, Paul K; Chakhava, George; Krog Josiassen, Mette; Lindsten, Annika; Sperling, Bjørn; Ettrup, Anders; Cady, Roger
偏头痛
神经科学
发表日期：2022
文献求助 收藏

Effects of Intravenous Eptinezumab vs Placebo on Headache Pain and Most Bothersome Symptom When Initiated During a Migraine Attack: A Randomized Clinical Trial

静脉注射依普汀单抗与安慰剂对偏头痛发作期间头痛及最困扰症状的影响：一项随机临床试验

期刊:Journal of the American Medical Association
影响因子:55
doi:10.1001/jama.2021.7665
Winner, Paul K; McAllister, Peter; Chakhava, George; Ailani, Jessica; Ettrup, Anders; Krog Josiassen, Mette; Lindsten, Annika; Mehta, Lahar; Cady, Roger
偏头痛
神经科学
发表日期：2021
文献求助 收藏